SCHEMBL6316460

SCHEMBL6316460

COc1nc2c(nc1C=Cc1ccccc1)c(=O)n(C)c(=O)n2C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 1/20 0.48
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
GLA P06280 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTT P42858 3/20 0.44
MAOB P27338 2/20 0.44
MAOA P21397 1/20 0.44
ADORA2A P29274 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323397 0.81 KDM4E (0.54) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL6314769 0.77 ALDH1A1 (0.64) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL6315474 0.73 KDM4E (0.53) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5440337 0.73 KDM4E (0.53) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL6321029 0.73 KDM4E (0.50) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5434751 0.71 ALDH1A1 (0.61) ALDH1A1KDM4EGAAHPGDGLA
SCHEMBL8219137 0.70 KDM4E (0.48) ALDH1A1KDM4EGAAHPGDSMN1; SMN2
SCHEMBL7402395 0.69 ADORA2A (0.76) ALDH1A1KDM4EHSD17B10HPGDGLA
SCHEMBL7288931 0.69 ADORA2A (0.76) ALDH1A1KDM4EHSD17B10HPGDGLA
SCHEMBL3668402 0.68 KDM4E (1.00) ALDH1A1KDM4EHSD17B10GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 ALDH1A1 1744/4885KDM4E 1278/4885HSD17B10 3654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.